Mopidevi, India

Lokeswara Rao Madivada

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lokeswara Rao Madivada: Innovator in Pharmaceutical Sciences

Introduction

Lokeswara Rao Madivada is a notable inventor based in Mopidevi, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug formulations. His work focuses on enhancing the efficacy and stability of pharmaceutical compounds.

Latest Patents

Lokeswara Rao Madivada holds a patent for "Enzalutamide polymorphic forms and its preparation." This patent relates to the crystalline and amorphous forms of Enzalutamide, a drug used in the treatment of prostate cancer. The application further discusses amorphous solid dispersions of Enzalutamide with pharmaceutically acceptable carriers. Additionally, it outlines a process for the preparation of Form R1 of Enzalutamide. He has 1 patent to his name.

Career Highlights

Lokeswara Rao Madivada is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality in drug development. His role at the company allows him to contribute to the advancement of pharmaceutical technologies and improve patient outcomes.

Collaborations

Throughout his career, Lokeswara has collaborated with talented professionals in the field. Some of his notable coworkers include Vishweshwar Peddy and Rajesham Boge, who have worked alongside him on various projects.

Conclusion

Lokeswara Rao Madivada is a distinguished inventor whose work in pharmaceutical sciences has the potential to impact the treatment of serious medical conditions. His innovative approach to drug formulation exemplifies the importance of research and development in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…